Determination of oligonucleotide ISIS 2922 in nanoparticulate delivery systems by capillary zone electrophoresis.
ISIS 2922 is an antisense oligonucleotide with antiviral activity against cytomegalovirus. However, its rapid degradation in biological fluids and its low capacity for diffusion across cell membranes limit its therapeutical use. One possibility to overcome these drawbacks consists of using nanoparticles as drug carriers. The aim of this study was to develop an analytical method for determining the amount of ISIS 2922 loaded into albumin nanoparticles. For this purpose, capillary zone electrophoresis (CZE) was performed on a fused-silica capillary filled with borate buffer (12.5 mM, pH 9.5). Paracetamol was used as an internal standard and a diode-array detection system was set at 270 nm. Under these conditions, the limit of quantitation of ISIS 2922 was 1.27 microg and the precision and accuracy of the method did not exceed 7%. Moreover, the use of paracetamol as internal standard and the quantification by means of a 'corrected area' procedure enabled us to reduce the peak variability and accurately determine the amount of oligonucleotide loaded in the albumin nanoparticles. In summary, this assay is a selective and sensitive CZE method for the accurate quantitation of ISIS 2922 oligonucleotide in albumin nanoparticles.
Arnedo
A
A
Centro Galénico, Departamento de Farmacia y Tecnologia Farmaceutica, Universidad de Navarra, Pamplona, Spain.
Campanero
M A
MA
Espuelas
S
S
Renedo
M J
MJ
Irache
J M
JM
D000998:Antiviral Agents / Q000032:analysis*; D001483:Base Sequence; D004337:Drug Carriers; D019075:Electrophoresis, Capillary / Q000379:methods*; D010316:Particle Size; D012015:Reference Standards; D015203:Reproducibility of Results; D013873:Thionucleotides / Q000032:analysis*
D000998:Antiviral Agents; D004337:Drug Carriers; D013873:Thionucleotides; C091346:fomivirsen